Advertisement
Screener

Repare Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price

Repare Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price

Repare Therapeutics Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $13.64 per share as of 2024-12-31, per its 10-K filed 2025-03-03.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2025-03-03

  • 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $13.64.
  • 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $13.00.
  • 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $11.41.
  • 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $6.28.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
2024-12-31$13.64
10-K · filed 2025-03-03
2023-12-31$13.00
10-K · filed 2024-02-28
2022-12-31$11.41
10-K · filed 2023-02-28
2021-12-31$6.28
10-K · filed 2022-03-01
2020-12-31$1.96
10-K · filed 2021-03-04
2019-12-31$1.69
10-K · filed 2021-03-04